Snap-8
An acetylated octapeptide studied for topical effects on expression line formation through SNAP-25 / SNARE complex interference.
Molecular Structure
Amino Acid Sequence
Molecular Formula
Molecular Weight
Half-Life
CAS Number
What is Snap-8?
Snap-8 is the cosmetic industry name for acetyl octapeptide-3, a topical peptide developed by Lipotec (now part of Lubrizol) as an extended analog of the more widely known acetyl hexapeptide-8 (commonly marketed as Argireline). Both peptides act through a similar mechanism, targeting the SNARE complex involved in neurotransmitter release from motor neurons, but Snap-8 was designed with structural modifications intended to provide enhanced potency and skin penetration.
Snap-8 is notable in research as one of the most widely studied “neurotransmitter-inhibiting” cosmetic peptides, designed to produce some of the muscle-relaxing effects of botulinum toxin through topical application rather than injection. The conceptual basis is well-grounded scientifically since botulinum toxin works by cleaving SNAP-25, a key SNARE complex protein, but the practical effectiveness of topical peptide mimetics is more modest than injected botulinum toxin and remains the subject of ongoing research. The compound has been used in commercial cosmetic formulations since the mid-2000s.
Mechanism of action
Snap-8’s mechanisms of action have been investigated across multiple pathways:
- SNAP-25 mimetic activity: The peptide is designed to compete with native SNAP-25 for binding within the SNARE complex, theoretically reducing the efficiency of vesicle fusion and neurotransmitter release at motor neuron terminals.
- Reduced neurotransmitter release: Through SNARE complex interference, the peptide aims to decrease acetylcholine release at facial muscle motor end plates.
- Reduced muscle contraction: Decreased acetylcholine signaling theoretically results in reduced contraction of small facial expression muscles, particularly those involved in dynamic wrinkle formation.
- Topical delivery considerations: Effects depend on the peptide reaching deeper skin layers where motor nerve terminals are located, a delivery challenge given the hydrophilic nature and molecular size of peptides.
- Effect magnitude relative to botulinum toxin: Unlike botulinum toxin, which enzymatically cleaves SNAP-25 with effects lasting months, Snap-8 acts through competitive binding interference with effects that, when present, are modest and temporary.
These pathways are characterized primarily in cosmetic research and manufacturer-sponsored studies.
Research applications
Snap-8 has been investigated across several research domains, with the most active areas including:
- Expression line reduction: Manufacturer-sponsored studies have reported reductions in wrinkle depth measurements with topical Snap-8 application, with effects typically observed after 4-8 weeks of consistent use. Effects are most pronounced for dynamic expression lines formed by repeated facial movements.
- Combination cosmetic formulations: Snap-8 is frequently formulated in combination with other cosmetic peptides and actives, including GHK-Cu (collagen synthesis), Matrixyl (palmitoyl pentapeptide-4), and retinoids, to target multiple aspects of skin aging simultaneously.
- Skin penetration research: Studies have examined the delivery challenges associated with peptide penetration through the stratum corneum, an active area of cosmetic science research investigating various penetration enhancers and delivery vehicles.
- Independent efficacy research: Independent studies have produced more variable findings regarding effectiveness compared with manufacturer-sponsored data, with the general scientific consensus being that effects when present are modest and substantially less than those of injected botulinum toxin.
- Comparative cosmetic peptide research: Research has compared Snap-8 with related compounds including its predecessor acetyl hexapeptide-8 (Argireline), with comparative effectiveness data informing cosmetic formulation decisions.
This compound is intended for laboratory research use only. It has not been approved for human therapeutic use by any regulatory agency.
Storage & reconstitution
In its lyophilized form, Snap-8 tolerates ambient temperatures during shipping but should be stored long-term at -20°C, protected from light. Properly stored lyophilized peptide remains stable for 24 months or longer.
In cosmetic formulation contexts, Snap-8 is typically incorporated at 3-10% of finished products and maintains stability within appropriate pH ranges (5.0-6.5) with appropriate preservative systems. For research-grade reconstituted solutions, storage refrigerated at 2-8°C with use within 28 days is standard. Avoid repeated freeze-thaw cycles, which can degrade peptide structure and reduce activity.
Visual inspection should be performed before each use. The reconstituted solution should be clear and colorless. Reject any solution that appears cloudy, discolored, or contains visible particulate matter.
For step-by-step reconstitution calculations, see our reconstitution calculator.
For laboratory research use only. The compound described on this page is intended exclusively for in vitro research and laboratory experimentation by qualified researchers and is not for human or veterinary use. It is not a drug, food, dietary supplement, or cosmetic, and has not been approved by the FDA, Health Canada, EMA, or any other regulatory authority for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. The information provided on this page is for educational and reference purposes only and does not constitute medical advice. By accessing this content you confirm that you are a qualified researcher purchasing for legitimate laboratory purposes.